HOME >> BIOLOGY >> NEWS
Pioneering experiments testing effects of greenhouse gases on crops

CHAMPAIGN, Ill. Portions of 40 acres of University of Illinois farmland this summer are sprouting soybeans grown in the presence of carbon dioxide levels forecast for the year 2050. Next summer, elevated levels of ozone will join the mix in a first-of-its-kind experiment called SoyFACE.

"When you consider the importance of the Midwest in terms of global food security, it is important to do this research here," said Stephen P. Long, a photosynthesis expert and the Robert Emerson Professor of Plant Biology at the UI. "Up to now, experiments related to global warming on many crops have been done in locations on the periphery of major food production areas."

Researchers want to know how soybeans may be affected, and what scientists might do to assure the integrity of yields and quality as the climate changes. By 2050, carbon dioxide levels are expected to be about 1.5 times greater than the current 370 parts per million, while daytime ozone levels during the growing season could peak on average at 80 parts per billion (now 60 parts per billion).

SoyFACE (Free Air gas Concentration Enrichment) is the first test of crop growth in the presence of both increased carbon dioxide and ozone. Five UI departments, the USDA-ARS and Illinois State Water Survey, as well as researchers from four other nations and two other U.S. universities are participating this summer.

Four control and four experimental 70-foot-diameter rings currently surround 24 varieties of soybeans. The experimental rings have ABS plastic pipes that deliver at crop level a precisely regulated flow of carbon dioxide, based on wind speed and direction, pumped from a 50-ton solar-powered tank.

Next summer, soybeans will grow on an adjacent 40 acres dotted with 24 of the octagon-shaped rings. Four rings will pump carbon dioxide, four will provide just ozone and four will provide ozone and carbon dioxide. Natural conditions will exist in an equal number of control rings for each test
'"/>

Contact: Jim Barlow
b-james3@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
2-Jul-2001


Page: 1 2

Related biology news :

1. Pioneering AIDS researcher to speak at UH
2. Pioneering discoveries, pursuing new knowledge, fostering partnerships
3. Pioneering flu researcher wins major Imperial scientific award
4. Pioneering study compares 13 vertebrate genomes
5. UFS Mcknight Brain Institute researchers: Pioneering spinal cord procedure appears safe
6. Pioneering evolutionist Ledyard Stebbins dies at age 94
7. Pioneering Research Could Lead To Treatment
8. Sandia experiments may reduce possibility of future water wars
9. APS recognizes Intel high school finalists for experiments in physiology
10. BioScience seeks nominations of beauteous experiments
11. ALife experiments show how complex functions can evolve

Post Your Comments:
(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
(Date:7/25/2014)... A new study by researchers from the University ... tiny nanosystems function, unlocking the potential to create ... study, which has been published in the prestigious ... a novel laser technique to examine in rich ... a small cluster containing an acetylene molecule and ...
(Date:7/25/2014)... 25, 2014 Lawrence Livermore scientists Charles ... Reuters list of " The World's Most Influential Scientific ... the 3,000 researchers who were identified by analyzing citation ... who published the highest-impact work (2002-2012 and 2012-2013). The ... combustion modeling . , "This recognition is a ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
Cached News: